Where docs get info: Other docs

Most doctors (74% of 2,982 respondents) rated colleagues as their most important source of new medical developments, followed by CME meeting attendance (71%) and medical journals (69%), a study shows.
Colleagues, journals and CME meetings—in that order—also scored the highest in reach (i.e., how often respondents said they had been exposed) among the 40 information sources included in Kantar Media's Sources and Interactions 2011 study, conducted in the first and second quarters.
Eliciting lower scores, dinner meetings rated a 75% on the reach scale. Pharma reps didn't make the list of top sources.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.